Entropy Technologies LP Sells 10,138 Shares of Danaher Corporation $DHR

Entropy Technologies LP lowered its holdings in shares of Danaher Corporation (NYSE:DHR) by 26.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 28,307 shares of the conglomerate’s stock after selling 10,138 shares during the period. Entropy Technologies LP’s holdings in Danaher were worth $5,612,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of DHR. Tyche Wealth Partners LLC purchased a new position in Danaher during the third quarter valued at $462,000. Ceredex Value Advisors LLC boosted its holdings in Danaher by 1.6% in the second quarter. Ceredex Value Advisors LLC now owns 249,377 shares of the conglomerate’s stock worth $49,262,000 after acquiring an additional 3,862 shares in the last quarter. Weitz Investment Management Inc. grew its stake in shares of Danaher by 6.1% in the second quarter. Weitz Investment Management Inc. now owns 526,950 shares of the conglomerate’s stock worth $104,094,000 after acquiring an additional 30,300 shares during the last quarter. Lockheed Martin Investment Management Co. grew its stake in shares of Danaher by 49.4% in the third quarter. Lockheed Martin Investment Management Co. now owns 25,340 shares of the conglomerate’s stock worth $5,024,000 after acquiring an additional 8,380 shares during the last quarter. Finally, Johnson Investment Counsel Inc. increased its holdings in shares of Danaher by 2.9% during the third quarter. Johnson Investment Counsel Inc. now owns 664,705 shares of the conglomerate’s stock valued at $131,784,000 after acquiring an additional 18,744 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Price Performance

NYSE DHR opened at $186.39 on Friday. Danaher Corporation has a one year low of $171.00 and a one year high of $242.80. The stock has a 50-day moving average of $219.65 and a 200 day moving average of $215.49. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.51 and a current ratio of 1.87. The company has a market capitalization of $131.81 billion, a price-to-earnings ratio of 36.98, a PEG ratio of 2.63 and a beta of 0.93.

Danaher (NYSE:DHR) last posted its earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.14 by $0.09. Danaher had a net margin of 14.71% and a return on equity of 10.81%. The business had revenue of $6.84 billion for the quarter, compared to analysts’ expectations of $6.79 billion. During the same quarter in the prior year, the business earned $2.14 EPS. The business’s revenue for the quarter was up 4.6% compared to the same quarter last year. On average, sell-side analysts forecast that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Friday, March 27th will be issued a $0.40 dividend. This is an increase from Danaher’s previous quarterly dividend of $0.32. This represents a $1.60 annualized dividend and a yield of 0.9%. The ex-dividend date is Friday, March 27th. Danaher’s dividend payout ratio is 25.40%.

Insider Transactions at Danaher

In other Danaher news, EVP Gregory M. Milosevich sold 1,320 shares of Danaher stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $208.01, for a total value of $274,573.20. Following the completion of the sale, the executive vice president owned 5,099 shares of the company’s stock, valued at approximately $1,060,642.99. The trade was a 20.56% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 11.10% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on DHR shares. JPMorgan Chase & Co. upped their price target on shares of Danaher from $270.00 to $275.00 and gave the stock an “overweight” rating in a research note on Thursday, January 29th. Wells Fargo & Company raised their price objective on shares of Danaher from $230.00 to $240.00 and gave the company an “equal weight” rating in a research note on Monday, December 15th. The Goldman Sachs Group dropped their target price on shares of Danaher from $270.00 to $265.00 and set a “buy” rating on the stock in a research note on Thursday, January 29th. Guggenheim increased their price target on shares of Danaher from $250.00 to $275.00 and gave the company a “buy” rating in a report on Friday, January 2nd. Finally, Robert W. Baird set a $251.00 price target on shares of Danaher in a research report on Thursday, January 29th. Twenty equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $253.86.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.